FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076233 [Registered on: 04/11/2024] Trial Registered Prospectively
Last Modified On: 13/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Diagnostic 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Which biopsy is better for diagnosing lung fluid build-up: cryo or forceps? 
Scientific Title of Study   Efficacy of semi-rigid thoracoscopic pleural cryo vs. forceps biopsy for evaluation of undiagnosed exudative pleural effusion. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Amal V Raj 
Designation  Senior resident 
Affiliation  VMMC and SJH 
Address  Department of Pulmonary Medicine Critical care and Sleep Medicine VMMC and SJH New Delhi

New Delhi
DELHI
110029
India 
Phone  7012136653  
Fax    
Email  vrajamal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rohit Kumar 
Designation  Associate Professor and Head of Department 
Affiliation  Vardhman Mahavir Medical College & Safdarjung Hospital  
Address  Department of Pulmonary Medicine Critical care and Sleep Medicine Vardhman Mahavir Medical College & Safdarjung Hospital, Ansari Nagar, New Delhi - 110029, India.

New Delhi
DELHI
110029
India 
Phone  9911218081  
Fax    
Email  dr.rohitkumar@mail.com  
 
Details of Contact Person
Public Query
 
Name  Amal V Raj 
Designation  Senior resident 
Affiliation  VMMC and SJH 
Address  Department of Pulmonary Medicine Critical care and Sleep Medicine VMMC and SJH New Delhi

New Delhi
DELHI
110029
India 
Phone  7012136653  
Fax    
Email  vrajamal@gmail.com  
 
Source of Monetary or Material Support  
VMMC & SAFDARJANG HOSPITAL Ministry of Health & F.W., Govt. of India NEW DELHI - 110 029  
 
Primary Sponsor  
Name  VMMC and SJH 
Address  VMMC and SJH New Delhi PIN 110029 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amal V Raj  SAFDARJUNG HOSPITAL  Room number 658,Department of Pulmonary medicine, Critical care and sleep medicine,Vardhman Mahavir Medical College & Safdarjung Hospital, Ansari Nagar,
New Delhi
DELHI 
7012136653

vrajamal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, VMMC and SJH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J90||Pleural effusion, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Semirigid thoracoscopic cryo biopsy  11 mm semirigid thoracoscopic cryo-probe duration- one to three hours for the total procedure  
Comparator Agent  Semirigid thoracoscopic forceps biopsy  Conventional thoracoscopic biopsy forceps duration- one to three hours for the total procedure 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1.Age more than 18 years
2.Presence of exudative pleural effusion
3.Absence of definitive diagnosis even after thoracocentesis and USG guided biopsy (if indicated)
 
 
ExclusionCriteria 
Details  1. Unstable respiratory, cardiovascular, hemodynamic condition or uncorrected coagulation defects
2. Small pleural space or multiple adhesions visualized in ultrasound necessitating the use of rigid thoracoscopy.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate and compare the diagnostic efficacy of semi-rigid thoracoscopic pleural cryobiopsy
versus forceps biopsy in cases of undiagnosed exudative pleural effusions 
baseline, 1-2 weeks post procedure 
 
Secondary Outcome  
Outcome  TimePoints 
1.To evaluate the major and minor complications of semi-rigid thoracoscopic pleural biopsy.
2. To assess and compare semi rigid thoracoscopic pleural cryobiopsy and forceps biopsy in terms of
specimen size, procedure duration and ease of making histopathological diagnosis 
Immediate post procedure
1-2 weeks post procedure 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   09/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Demographic and historical data of eligible patients will be documented, including age, sex,
radiological findings, and results of diagnostic thoracocentesis and ultrasound-guided biopsy if performed.
Patients will also undergo semirigid thoracoscopy if standard thoracocentesis and ultrasound-guided
biopsy are inconclusive. Pleural biopsies will be collected using a cryoprobe (19mm) and semirigid forceps
biopsy, with eight biopsies taken using flexible forceps and four using a cryoprobe.
The operator will assess the ease of biopsy acquisition using a visual analogue scale, documenting
post-biopsy bleeding and procedure duration.
Biopsies from each method will be tagged separately and sent for histopathological examination.
The samples will be followed up in the Pathology department to evaluate biopsy size, crush artifacts,
ease of diagnosis, and final diagnosis.
 
Close